It has been reported that treatment with xanthine oxidase inhibitor benzbromarone and dietary supplementation with L-arginine have protective effects against PAH (Sztormowska-Achranowicz et al., 2020). The gene discussed is XDH; the disease is pulmonary arterial hypertension.